Affiliation:
1. School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China
Abstract
Abstract:
Breast cancer is one of the most prevalent malignant diseases, and one of the main causes of mortality among women across the world. Despite advances in chemotherapy, drug resistance remains a major clinical concern, creating an urgent need to explore novel anti-breast cancer drugs. 1,2,3-triazole is a privileged moiety, and its derivatives could inhibit cancer cell proliferation and induce cell cycle arrest and apoptosis. Accordingly, 1,2,3-triazole derivatives possess profound ac-tivity against various cancers, including breast cancer. This review summarizes the latest progress related to the anti-breast cancer potential of 1,2,3-triazole derivatives, covering articles published from January 2017 to December 2021. The mechanisms of action and structure-activity relation-ships (SARs) are also discussed for the further rational design of more effective candidates.
Publisher
Bentham Science Publishers Ltd.
Reference122 articles.
1. Ehab M.; Elbaz M.; Profile of palbociclib in the treatment of metastatic breast cancer. Breast Cancer (Dove Med Press) 2016,8,83-91
2. Toppmeyer D.L.; Press M.F.; Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer. Cancer Med 2020,9(18),6463-6472
3. Loibl S.; Poortmans P.; Morrow M.; Denkert C.; Curigliano G.; Breast cancer. Lancet 2021,397(10286),1750-1769
4. Soguel L.; Durocher F.; Tchernof A.; Diorio C.; Adiposity, breast density, and breast cancer risk: Epidemiological and biological con-siderations. Eur J Cancer Prev 2017,26(6),511-520
5. International Agency for Research on Cancer. Breast 2020. Available
from:
(Accessed on: October 2021).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phytochemical Profile and Selective Anticancer Activity of Parietaria judaica L. Extracts;Molecules;2025-06-25
2. Synthesis and evaluation of quinolinvinyl-phenoxy-1,2,3-triazole-acetamide hybrids against breast cancer;Scientific Reports;2025-05-16
3. Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru(II)/Ir(III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment;Journal of Medicinal Chemistry;2025-02-05
4. Microwave expedited Cu(I) catalyzed regioselective 1,2,3-triazoles as Mycobacterium Tuberculosis H37Rv inhibitors, in vitro α-amylase and α-glucosidase inhibition, in silico studies;Journal of Molecular Structure;2025-02
5. Synthesis of novel (R)-Carvone-1,2,3-triazole hybrids: Network pharmacology, molecular docking, and dynamics simulation targeting tumor protein markers;Journal of Molecular Structure;2025-02